"...large companies are going to be hoarding cash and trying to survive the current global turmoil not doing large global deals for new products."
Most of the large pharma's have buckets of cash already. Also, pharma's earnings are not normally effected much by recessions.
Vitrogro will save health authorities heaps in care time, and as such will be a very attractive product indeed. It's easy to sell something that costs a dollar but saves fifty!
Buy & hold, imho.
Add to My Watchlist
What is My Watchlist?